Eli Lilly (LLY) Income from Continuing Operations (2009 - 2026)
Eli Lilly (LLY) posted Income from Continuing Operations of $7.1 billion for Q2 2026, up 25.3% from $5.66 billion a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Income from Continuing Operations (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Continuing Operations at Eli Lilly was $26.71 billion, up 93.6% year-over-year; for FY2025, it came in at $20.64 billion, up 94.9% from FY2024.
- Annual Income from Continuing Operations shows a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
- In prior years, Eli Lilly's Income from Continuing Operations was $10.59 billion in FY2024 (+102.1%), $5.24 billion in FY2023 (-16.1%), $6.24 billion in FY2022 (+11.9%) and $5.58 billion in FY2021 (-9.9%).
- Quarterly Income from Continuing Operations has run from a low of -$57.4 million in Q3 2023 to a high of $7.4 billion in Q1 2026 over five years.
- On a year-over-year basis, Income from Continuing Operations has increased in each of the last seven quarters, with growth averaging 133.5% over the last seven quarters.
- The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q3 2025, with growth of 475.3%; the weakest was Q2 2022, with a decline of 31.5%.
- According to Business Quant data, Income from Continuing Operations for the three prior quarters was $7.4 billion (Q1 2026), $6.64 billion (Q4 2025) and $5.58 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Vertex Pharmaceuticals | 133.42 Bn | 105.43 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Bn |
| Mar 31, 2026 | 7.40 Bn |
| Dec 31, 2025 | 6.64 Bn |
| Sep 30, 2025 | 5.58 Bn |
| Jun 30, 2025 | 5.66 Bn |
| Mar 31, 2025 | 2.76 Bn |
| Dec 31, 2024 | 4.41 Bn |
| Sep 30, 2024 | 970.30 Mn |
| Jun 30, 2024 | 2.97 Bn |
| Mar 31, 2024 | 2.24 Bn |
| Dec 31, 2023 | 2.19 Bn |
| Sep 30, 2023 | -57.40 Mn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Jun 30, 2022 | 952.50 Mn |
| Mar 31, 2022 | 1.90 Bn |
| Dec 31, 2021 | 1.73 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Eli Lilly Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();